In this edition of his quarterly column, Dr. Steensma answers the question, Where does the name myelodysplastic syndromes come from? The column will be published as a two-part series. In Part 1, Dr. Steensma described the history of the disease name. In Part 2 (below), he addresses the origins of the name.
So what is the etymology (word history) of “myelodysplastic syndromes?”
To begin with, “myelo-“ has as its origin the Greek word μυελός, meaning “marrow.” Interestingly, there are…
In this edition of his quarterly column for The MDS Beacon, Dr. Steensma answers the question, “Where does the name myelodysplastic syndromes come from?” The column will be published as a two-part series. In Part 1, Dr. Steensma describes the history of the disease name. In Part 2, he will address the origins of the name.
Although every English-speaking adult has heard the word “leukemia” and most people have at least some sense what sort of disease…
Patients with myelodysplastic syndromes (MDS) often feel fatigued – tired, worn out, weary, bushed, or “out of gas.” Many people suffering from MDS find that they just don’t have the stamina they used to have. Minor errands that patients once didn’t give a second thought to are now completely draining. As a result, patients may begin to avoid potentially strenuous tasks and feel that they are not able to enjoy life like they once did.
So many of my patients…
This edition of Dr. Steensma’s quarterly column is about participating in clinical trials. It will be published as a two-part series. In Part 1, Dr. Steensma described the different types of clinical trials and where to find them. In Part 2, he will address concerns that MDS patients may have about participating in clinical trials.
Patients often worry about whether they will have to pay to participate in clinical trials. Interventions that are performed specifically for a study (e.g.…